In October 2020, Ganatra et al. published a retrospective review of 187 adult patients treated with CD19 CAR T cells for non-Hodgkin lymphoma to detect the incidence of cardiomyopathy. This evidence concerns the gene CD19 and non-Hodgkin lymphoma.